Introduction
Vascular risk factors have been identified as relevant in the pathogenesis of glaucomatous optic neuropathy. Systemic and local vascular risk factors may result in vasosclerosis, capillary dropout, vasospasms or autoregulatory dysfunction and contribute to impaired ocular blood flow. [1] [2] [3] [4] [5] Systemic blood pressure data have been evaluated in various studies on glaucomatous optic neuropathy, and different results were reported. Arterial hypertension and hypotension, night-time blood pressure depression ('dipping'), haemodynamic crises and extensive hypertensive medication in arterial hypertension were reported to influence glaucomatous optic neuropathy. [6] [7] [8] [9] [10] [11] [12] [13] Ocular perfusion pressure is calculated as a function of intraocular pressure and mean arterial blood pressure. 4 Intraocular pressure fluctuation is known to be increased in open-angle glaucoma, 14 and if autoregulatory dysfunction is present in glaucoma, systemic blood pressure variability may contribute to ischaemic episodes at the optic nerve head.
Systemic blood pressure has different fluctuation rhythms under physiological conditions. Seasonal variability with lower blood pressure values in winter times, day and night-time rhythms with lower blood pressure during sleep, that is, physiological night-time blood pressure depression or blood pressure dip. And, short-time fluctuation during the day and the night, influenced by individual habits and activities. [15] [16] [17] In the presented study on ambulatory 24-h blood pressure monitoring, blood pressure variability was investigated in patients with normal tension glaucoma. Night-time and daytime blood pressure variability and night-time blood pressure depression ('dip') of systolic, diastolic and mean arterial blood pressure was calculated. Blood pressure measurements were performed every 30 min during day and night.
Patients and methods

Patients
In all, 51 patients with normal tension glaucoma (NTG) and 28 age-matched controls were included in this prospective study. The clinical and demographic data of all individuals are shown in Table 1 . All individuals including the control subjects obtained informed consent. Adherence to the Declaration of Helsinki for research involving human subjects is confirmed.
Patients with NTG had glaucomatous optic nerve head cupping and glaucomatous visual field defects as defined by the European glaucoma society (EGS), in the absence of retinal or neurological disease affecting the visual field. The diagnostic criteria for glaucomatous visual field loss are as follows. Field loss was considered significant when (a) glaucoma haemifield test was abnormal, (b) three points confirmed with Po0.05 probability of being normal (one of which should have Po0.01), not contiguous with the blind spot, or (c) corrected pattern s.d. (CPSD) was abnormal with Po0.05.
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All parameters were confirmed on two consecutive visual fields performed with Humphrey Visual Field Analyzer (full threshold program 24-2). All patients with NTG underwent diurnal intraocular pressure (IOP) measurements (Goldmann applanation tonometry) at 0800, 1200, 1600, 2000 and 2400) without any topical or systemic IOP-lowering medication to confirm the diagnosis. The IOP was neither measured nor documented in the patient's history above 21 mmHg. At the time of the study, 30 patients with NTG did not receive local IOPlowering medication. In all, 21 patients were on local IOP-lowering medications (b-blockers, adrenaline, carbonic anhydrase inhibitors, brimonidine, prostaglandins or combinations). None of the controls received local treatment.
In all subjects, visual acuity was 20/40 or better, and patients with refractive aberrations of more than 74 dioptres, or with diabetes mellitus were excluded from this study. The healthy control subjects had no history of ophthalmological disease. Automatic static white-on-white and short-wavelength automated perimetry did not reveal visual field loss.
All subjects had a detailed ophthalmological examination and patient's history was explored with special interest on cardiovascular risk factors (i.e. diagnosis of treated hypertension, arterial hypotension, history of cardiovascular events (e.g. myocardial infarction), nicotine abuse, obesity (body mass index 426)). Patients with diabetes were excluded from the study. No other systemic diseases were defined as exclusion criteria. The systemic medications were recorded, but only the status of treated arterial hypertension was included in the analysis.
Methods
Ambulatory blood pressure monitoring was performed in all subjects included in this prospective study with a SpaceLabs ambulatory blood pressure monitor 90207 (Space Labs Medical Inc., Redmond, WA, USA). Systolic and diastolic blood pressure values were measured, and the mean arterial blood pressure was calculated from each single measurement (diastolic blood pressure þ 1/3 (systolic blood pressureÀdiastolic blood pressure)). 4 Blood pressure measurements were performed every 30 min during the day and night. Blood pressure values were analysed separately for the day and for the night. In accordance to the 'Scientific Committee on noninvasive ambulatory blood pressure monitoring', 19 daytime was defined from 0800 to 2000, and night-time from 0000 to 0600. Blood pressure measurements between the defined time intervals were excluded form the analysis, in order to obtain a better separation between daytime activities and sleep. 20 All subjects were announced to sleep during the night-time interval.
The mean of the systolic, diastolic and mean arterial blood pressure was calculated from all single measurements for the day and night. A variability index was defined as the s.d. of all single blood pressure measurements during the day and the night. 21 Night-time blood pressure depression ('dip') was determined (i.e. (mean blood pressure during the dayÀmean blood pressure during the night)/mean blood pressure during the day). Patients were defined as dippers (night-time blood pressure depression 410%) and nondippers (nighttime blood pressure depression o10%).
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Visual field examinations were performed with the Humphrey Field Analyzer (Model 750, Humphrey-Zeiss, San Leandro, CA, USA) using the white-on-white 24-2 full threshold program. Horizontal and vertical cup-to-disc ratios were measured by digital image analysis of argon blue images (488 nm) of the optic nerve head.
For the statistical analysis of this study, one eye of each subject was randomly chosen. Blood pressure values and clinical data were compared with analysis of variance (ANOVA) as computed with StatView (SAS institute Inc., Cary, NC, USA). For post hoc testing calculations with Fisher's protected 
Results
The prevalence of treated arterial hypertension was not significantly different in patients with NTG and age-and sex-matched controls. No significant difference was found according to the number of subjects with arterial hypotension, the history of cardiovascular events (e.g. myocardial infarction), obesity or nicotine abuse ( Table 2) .
The mean daytime blood pressure values for systolic, diastolic and mean arterial blood pressures were not significantly different in patients with NTG and controls. Patients with NTG exhibited higher night-time diastolic mean arterial blood pressure values, whereas systolic blood pressure data were not significantly different (Table 3) .
The variability indices of night-time systolic, diastolic and mean arterial blood pressure measurements were significantly increased in patients with NTG compared to controls. Variability indices of daytime blood pressure values did not differ significantly ( Table 4) .
The night-time blood pressure depression of systolic, diastolic and mean arterial blood pressures was smaller in patients with NTG, but did not differ significantly between patients and controls ( Table 5) .
The number of patients with NTG and controls considered to be 'dippers' (i.e. night-time blood pressure depression 410%) was not significantly different for systolic, diastolic and mean arterial blood pressure measurements (Table 6 ).
Discussion
Ocular blood flow is a significant factor in the pathogenesis of glaucomatous optic neuropathy. [1] [2] [3] 5 Systemic blood pressure directly affects ocular perfusion pressure, and the impact of systemic blood pressure on glaucomatous optic neuropathy has been investigated in various studies in the past.
Arterial hypertension 7, 8, 11, [24] [25] [26] [27] and hypotension 6,9,10,28-32 were reported to be relevant in normal tension and primary open-angle glaucoma, though other studies could not detect a significant difference to controls. [33] [34] [35] [36] Diastolic perfusion pressures below 30 mmHg were related to a six-fold higher risk 
24-h blood pressure monitoring N Plange et al
for glaucoma compared to higher perfusion pressures. 37 Methodological aspects may account for conflicting results, as some studies were based on single blood pressure measurements, others on 24-h ambulatory blood pressure monitoring. Using 24-h blood pressure monitoring, the number of blood pressure measurements (i.e. time intervals between measurements) is a significant factor. Blood pressure measurements should be performed every 30 min during night and day, to gain a reliable number of values. 19 Furthermore, one has to consider if patients received treatment for arterial hypertension, and if control subjects were matched for the diagnosis of treated arterial hypertension, or not. In addition, extensive medical blood pressure reduction was postulated to possibly lead to decreased ocular perfusion, and thus may cause optic nerve ischaemia in glaucoma. 30, [38] [39] [40] [41] [42] The nighttime blood pressure depression ('dip') was reported to be increased in NTG 12, 13, 41 and POAG. 28, 36, 43 In contrast, other investigators could find an even smaller dip in patients with progressive glaucoma. 24, 44 The dip at night is considered to be physiological, and reaches 10-20% of daytime blood pressure values in a healthy population. 17, 45, 46 Interestingly, all studies on patients with glaucoma, including the studies that reported significant differences to control subjects found a mean nighttime blood pressure reduction in this physiological range. 12, 16, 28, 34, 36, 41, [43] [44] [45] [46] [47] In the presented study, the prevalence of treated arterial hypertension and cardiovascular risk factors was not significantly different in patients with NTG and controls based on the patient's medical history ( Table 2 ). The medications and systemic diseases other than the named cardiovascular risk factors were not analysed in this study. The number of patients is too limited to perform a reliable subgroup analysis. Further larger scaled studies need to investigate the influence of various blood pressure or local IOP-lowering medications (e.g. b-blockers) on blood pressure variability. The blood pressure measurements performed with 24-h ambulatory blood pressure monitoring were not significantly different during the day, and patients with NTG showed higher blood pressure levels at night (Table 3 ). In addition, the night-time blood pressure depression and the number of subjects considered to be 'dippers' (i.e. night-time blood pressure reduction 410%) were not significantly different in patients with NTG or controls (Tables 5 and 6 ).
Beside day-night fluctuations, systemic blood pressure shows short-time variability that can be measured with 24-h ambulatory blood pressure monitoring. During the day, blood pressure is mainly influenced by individual habits, but to a minor part at night. However, it must be considered that sleep is indeed also affected by daily activities and incidents. 24-h ambulatory blood pressure monitoring allows the measurement of such blood pressure fluctuations if blood pressure measurements are performed at least every 30 min. 19 We omitted the blood pressure measurements from 0600 to 0800 and from 2000 to 0000 in accordance to the definition of day and night described in Methods. The intention was to investigate blood pressure levels and variability during sleep, as previous investigators reported the night-time blood pressure levels to be reduced in glaucoma. 12, 13, 28, 36, 41, 43 To increase the comparability of the measurements between subjects, the time intervals with the largest individual differences concerning going to sleep or waking up were not analysed.
In the presented study, patients with NTG exhibited an increased blood pressure variability of systolic, diastolic and mean arterial blood pressure data at night. The variability index to describe blood pressure fluctuations was defined as the s.d. of the single blood pressure measurements according to the Scientific Comettee. 19 Kashiwagi reported increased blood pressure variability in progressive NTG. 24 Béchetoille found higher systolic blood pressure variability in focal ischaemic glaucoma compared to POAG. 6 However, blood pressure measurements were only performed every 60 min at night, and no control subjects were included in this study. In contrast, in the presented study blood pressure measurements were performed every 30 min. Interestingly, increased blood pressure variability seems to be related to increased end-organ damage in patients with systemic hypertension. 48, 49 Arterial hypertension as a chronic disease induces small vessel alterations and vasosclerosis, and will lead to end-organ damage with increased peripheral 10, 30, 42 However, in mild hypertension and short duration of the disease, the increased blood pressure levels probably effect higher perfusion pressures and may be protective against ischaemia of ocular tissues. 10, 37 In contrast, hypertension increases the autoregulatory niveau to a higher level, and increases the susceptibility to low perfusion pressures. 6 Blood flow depends on perfusion pressure and peripheral vascular resistance. 4 Perfusion pressure is influenced by hypertension, hypotension, nighttime blood pressure depression and, beside intraocular pressure, blood pressure fluctuations. Increased blood pressure fluctuations effect higher perfusion pressure variability, and may induce ischaemia of ocular tissues in glaucoma, if the autoregulatory capacity of ocular and optic nerve head blood flow is passed over. Maybe, not the absolute blood pressure level alone, 24, 36, 38, 43, 44, 47 but fluctuations of night-time blood pressure may account for deficits of ocular perfusion pressure. In addition, ocular perfusion pressure is influenced by diurnal intraocular pressure fluctuations. Higher diurnal IOP fluctuations during the daytime are a well-known phenomenon in glaucoma. [50] [51] [52] Increased intraocular pressure variability will lead to a further variability in ocular perfusion pressure. However, IOP measurements at night in supine position did not reveal differences in IOP variation between glaucoma patients and controls. 52 Intraocular pressure fluctuations may have various different patterns with different peaking times. This highlights the importance of measuring diurnal IOP curves in glaucoma patients. 53 A recent report of the Advanced Glaucoma Intervention Study (AGIS) identified IOP fluctuations during followup of the study being associated with glaucoma progression. 54 In conclusion, night-time blood pressure fluctuations could be a relevant factor in the pathogenesis of NTG. This study could not confirm a reduced blood pressure level in NTG patients. In contrast, blood pressure was increased at night in the presented NTG subjects. Longitudinal studies need to clarify the significance for development and progression of glaucomatous optic neuropathy.
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